Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

B cells facilitate platelet production mediated by cytokines in patients with essential thrombocythaemia.

Liu CC, Wang SC, Kao CW, Hsieh RK, Chang MC, Chang YF, Lim KH, Chen CG.

Thromb Haemost. 2014 Sep 2;112(3):537-50. doi: 10.1160/TH13-11-0949. Epub 2014 Jun 5.

PMID:
24898769
2.

Thrombopoietin, but not cytokines binding to gp130 protein-coupled receptors, activates MAPKp42/44, AKT, and STAT proteins in normal human CD34+ cells, megakaryocytes, and platelets.

Majka M, Ratajczak J, Villaire G, Kubiczek K, Marquez LA, Janowska-Wieczorek A, Ratajczak MZ.

Exp Hematol. 2002 Jul;30(7):751-60.

PMID:
12135673
3.

Decreased production of interleukin-10 and transforming growth factor-β in Toll-like receptor-activated intestinal B cells in SAMP1/Yit mice.

Mishima Y, Ishihara S, Aziz MM, Oka A, Kusunoki R, Otani A, Tada Y, Li YY, Moriyama I, Oshima N, Yuki T, Amano Y, Matsumoto S, Kinoshita Y.

Immunology. 2010 Dec;131(4):473-87. doi: 10.1111/j.1365-2567.2010.03318.x. Erratum in: Immunology. 2011 Mar;132(3):451.

4.

The production of JAK2 wild-type platelets is not downregulated in patients with JAK2 V617F mutant-positive essential thrombocythaemia.

Lambert JR, Gale RE, Linch DC.

Br J Haematol. 2009 Apr;145(1):128-30. doi: 10.1111/j.1365-2141.2009.07597.x. Epub 2009 Jan 12.

PMID:
19222478
5.

Megakaryopoiesis and platelet function in polycythemia vera and essential thrombocythemia patients with JAK2 V617F mutation.

Hattori N, Fukuchi K, Nakashima H, Maeda T, Adachi D, Saito B, Yanagisawa K, Matsuda I, Nakamaki T, Gomi K, Tomoyasu S.

Int J Hematol. 2008 Sep;88(2):181-8. doi: 10.1007/s12185-008-0129-9. Epub 2008 Jul 10.

PMID:
18612778
6.
7.

Paracrine regulation of megakaryo/thrombopoiesis by macrophages.

D'Atri LP, Pozner RG, Nahmod KA, Landoni VI, Isturiz M, Negrotto S, Schattner M.

Exp Hematol. 2011 Jul;39(7):763-72. doi: 10.1016/j.exphem.2011.03.009. Epub 2011 Apr 15.

PMID:
21549176
8.

Is the absence of JAK2 mutation a risk factor for bleeding in essential thrombocythemia? An analysis of 106 patients.

Patriarca A, Pompetti F, Malizia R, Iuliani O, Di Marzio I, Spadano A, Dragani A.

Blood Transfus. 2010 Jan;8(1):21-7. doi: 10.2450/2009.0004-09.

9.

Efficient in vitro megakaryocyte maturation using cytokine cocktails optimized by statistical experimental design.

Cortin V, Garnier A, Pineault N, Lemieux R, Boyer L, Proulx C.

Exp Hematol. 2005 Oct;33(10):1182-91.

PMID:
16219540
10.

Long-term platelet production assessed in NOD/SCID mice injected with cord blood CD34+ cells, thrombopoietin-amplified in clinical grade serum-free culture.

Mattia G, Milazzo L, Vulcano F, Pascuccio M, Macioce G, Hassan HJ, Giampaolo A.

Exp Hematol. 2008 Feb;36(2):244-52. Epub 2007 Nov 26.

PMID:
18023520
11.
12.

Semaphorin 7A inhibits platelet production from CD34+ progenitor cells.

Jaimes Y, Gras C, Goudeva L, Buchholz S, Eiz-Vesper B, Seltsam A, Immenschuh S, Blasczyk R, Figueiredo C.

J Thromb Haemost. 2012 Jun;10(6):1100-8. doi: 10.1111/j.1538-7836.2012.04708.x.

13.

JAK2 V617F mutation is associated with increased risk of thrombosis in Chinese patients with essential thrombocythaemia.

Wong RS, Cheng CK, Chan NP, Cheng SH, Wong WS, Lau KM, Cheng G, Ng MH.

Br J Haematol. 2008 Jun;141(6):902-4. doi: 10.1111/j.1365-2141.2008.07127.x. Epub 2008 Apr 10. No abstract available.

PMID:
18410451
14.

Comparison of JAK2V617F mutation assessment employing different molecular diagnostic techniques.

Veneri D, Capuzzo E, de Matteis G, Franchini M, Baritono E, Benati M, Solero GP, Ambrosetti A, Quaresmini G, Pizzolo G.

Blood Transfus. 2009 Jul;7(3):204-9. doi: 10.2450/2009.0070-08.

15.

Tyk2 mutation homologous to V617F Jak2 is not found in essential thrombocythaemia, although it induces constitutive signaling and growth factor independence.

Shide K, Shimoda K, Kamezaki K, Kakumitsu H, Kumano T, Numata A, Ishikawa F, Takenaka K, Yamamoto K, Matsuda T, Harada M.

Leuk Res. 2007 Aug;31(8):1077-84. Epub 2006 Sep 29.

PMID:
17011030
16.

Defective macrophage function in neonates and its impact on unresponsiveness of neonates to polysaccharide antigens.

Chelvarajan RL, Collins SM, Doubinskaia IE, Goes S, Van Willigen J, Flanagan D, De Villiers WJ, Bryson JS, Bondada S.

J Leukoc Biol. 2004 Jun;75(6):982-94. Epub 2004 Feb 24.

PMID:
14982942
17.

JAK2V617F mutation and allele burden are associated with distinct clinical and morphological subtypes in patients with essential thrombocythaemia.

Pich A, Riera L, Beggiato E, Nicolino B, Godio L, Campisi P, Sismondi F, di Celle PF.

J Clin Pathol. 2012 Oct;65(10):953-5. Epub 2012 Jun 20. No abstract available.

PMID:
22718845
18.

The activation of CD14, TLR4, and TLR2 by mmLDL induces IL-1β, IL-6, and IL-10 secretion in human monocytes and macrophages.

Chávez-Sánchez L, Chávez-Rueda K, Legorreta-Haquet MV, Zenteno E, Ledesma-Soto Y, Montoya-Díaz E, Tesoro-Cruz E, Madrid-Miller A, Blanco-Favela F.

Lipids Health Dis. 2010 Oct 14;9:117. doi: 10.1186/1476-511X-9-117.

19.

JAK2-V617F mutation analysis of granulocytes and platelets from patients with chronic myeloproliferative disorders: advantage of studying platelets.

Toyama K, Karasawa M, Yamane A, Irisawa H, Yokohama A, Saitoh T, Handa H, Matsushima T, Sawamura M, Miyawaki S, Murakami H, Nojima Y, Tsukamoto N.

Br J Haematol. 2007 Oct;139(1):64-9.

PMID:
17854308
20.

Effect of simvastatin or its combination with ezetimibe on Toll-like receptor expression and lipopolysaccharide - induced cytokine production in monocytes of hypercholesterolemic patients.

Moutzouri E, Tellis CC, Rousouli K, Liberopoulos EN, Milionis HJ, Elisaf MS, Tselepis AD.

Atherosclerosis. 2012 Dec;225(2):381-7. doi: 10.1016/j.atherosclerosis.2012.08.037. Epub 2012 Sep 24.

PMID:
23062767

Supplemental Content

Support Center